Evidence map›Paper›PMID 41133149›Full record

ArticleFrontiers in medicine2025

Increased risk of deep vein thrombosis, pulmonary embolism, and all-cause mortality in chronic venous disorder: a large-scale retrospective cohort study.

Eva Lotta Moderegger, Sören Dräger, Sophie L Preuss, Artem Vorobyev, Patrick Terheyden, Khalaf Kridin, Katja Bieber, Ralf J Ludwig, Birgit Kahle, Philip Curman

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Eva Lotta Moderegger *Department of Dermatology, University Clinic of Schleswig Holstein, Campus Lübeck, Lübeck, Germany.
Sören Dräger *Department of Dermatology, University Clinic of Schleswig Holstein, Campus Lübeck, Lübeck, Germany.
Sophie L PreussDepartment of Dermatology, University Clinic of Schleswig Holstein, Campus Lübeck, Lübeck, Germany.
Artem VorobyevDepartment of Dermatology, University Clinic of Schleswig Holstein, Campus Lübeck, Lübeck, Germany.
Patrick TerheydenDepartment of Dermatology, University Clinic of Schleswig Holstein, Campus Lübeck, Lübeck, Germany.
Khalaf KridinLübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.
Katja BieberLübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.
Ralf J Ludwig *Department of Dermatology, University Clinic of Schleswig Holstein, Campus Lübeck, Lübeck, Germany.
Birgit Kahle *Department of Dermatology, University Clinic of Schleswig Holstein, Campus Lübeck, Lübeck, Germany.
Philip Curman *Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Chronic venous disorder (CVD), often overlooked as a significant medical burden, has recently been linked to severe health risks, especially deep vein thrombosis (DVT), and pulmonary embolism (PE). However, large-scale data are lacking. Specifically, the impact of CVD severity on the risk of thromboembolic events and the impact of procedural interventions on these risks are unknown. Methods: A retrospective cohort study of mortality and serious adverse events was conducted using electronic health records derived from the TriNetX database. Propensity-score matching and sensitivity analyses were performed to mitigate bias. Results: We included 463,313 patients with CVD. An increased risk of superficial vein thrombosis [SVT; hazard ratio (HR), 19.0, 95% confidence interval (CI) 17.1-21.0, Discussion: Independently of disease severity, CVD entails an increased risk for venous thromboembolic events and all-cause mortality. In CVD patients, procedural interventions are associated with reduced risks for DVT, PE and all-cause mortality. Confirmation of these potentially clinically relevant findings necessitates prospective randomized trials.

Indexed as

chronic venous diseasechronic venous disorderchronic venous insufficiencymortalitypulmonary embolismthrombosisTriNetXvaricose veins

Identifiers

PMID41133149
PMCPMC12540070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.